02361 中康控股
SINOHEALTH HLDG
SINOHEALTH HLDG
| Listing Date | 2022/07/12 |
| Listing Price | 5.360 |
Quote
Subscription Result
- Subscription Rate2.21x
- Guarantee One Lot Size3 lot
- One Lot Success Rate50.02%
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
Sinohealth Holdings primarily provides healthcare insight solutions to address the sales and marketing needs of medical product manufacturer clients. These solutions are based mainly on retail data. Its partnering pharmacies are important business partners who primarily supply it with retail data, forming a key component of database.
According to the iResearch Report, the Group ranked first for the medical products and channels segment of healthcare insight solutions in the PRC in terms of (i) revenue in 2021, and (ii) number of top medical product manufacturers and number of corporate clients served in 2020.
Its business model is supported by three core pillars, namely, (i) Sinohealth Engine which is a technology and data platform; ; (ii) Healthcare Industry Participant Networks and (iii) Big Data & AI Lab.
The Group have developed a broad client base covering key stakeholders in the healthcare industry chain, including medical product manufacturers, pharmacies, physical examination institutions, investment institutions, regulators, medical service institutions and insurance companies.
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 500 |
GLOBAL OFFERING
| No. of Offer Shares | 75.00M shares |
| No. of International Offer Shares | 67.50M shares |
| No. of HK Offer Shares | 7.50M shares |
| Offer Price | $5.36 - $6.96 |
| Stock Code | 2361 |
| Sponsor(s) | BNP Paribas Securities (Asia) Limited |
| Underwriter(s) | BNP Paribas Securities (Asia) Limited, CCB International Capital Limited, Orient Securities (Hong Kong) Limited, Haitong International Securities Company Limited, UOB Kay Hian (Hong Kong) Limited, Guotai Junan Securities (Hong Kong) Limited, Eddid Securities and Futures Limited, Zhongtai International Securities Limited, Futu Securities International (Hong Kong) Limited, Innovax Securities Limited, Fosun Hani Securities Limited, Livermore Holdings Limited |
TIME TABLE
| Application Period | Jun 28 (Tue) - noon, Jul 05 (Tue) |
| Price Determination Date | Jul 05 (Tue) |
| Result Announcement Date | On or before Jul 11 (Mon) |
| Result Announcement Date | On or before Jul 11 (Mon) |
| Dealings in Shares commence on | Jul 12, 2022. (Tue) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $5.36 - $6.96 |
| Capitalization | 2.41B - 3.13B |
| NAV / share ($) | $1.87 - $2.14 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 6.16, the net proceeds raised would be HKD 395.40M, of which |
| 50.8% : Upgrade and enhance SaaS products with a focus on Smart Decision Cloud, Smart Retail Cloud and Smart Medical Cloud, and their marketing and promotion |
| 49.2% : Conduct further research and development of technology and data warehouse, and in particular for AI technologies and the middleware for Sinohealth Engine |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).